苦参碱抑制HepG2细胞增殖及其剂量与抑制方式关系的研究
苦参碱,药理学;苦参碱,投药和剂量;肝肿瘤,病理学;肿瘤细胞,培养的,药物作用,项目负责人,Correspondenceto,StudyonmatrineinhibitingproliferationofHepG2cellandtherelationbetweenitsdosageandinhibitingstyle,
中国人民解放军第三军医大学医学检验系临床 1生化教研室 2临床检验教研室 重庆市 400038司维柯,女,1958-10-08生,山西省晋城市人, 汉族. 1986年重庆医科大学医学检验系毕业,1995/2000年分别获得医学硕士、博士学位. 讲师,教研室副主任,主要从事肿瘤细胞增殖调控和肝脏疾病实验室诊断方面的研究,已发表论文20篇.
项目负责人 司维柯,400038,重庆市,中国人民解放军第三军医大学临床生化教研室.
1Department of Clinical Biochemistry, Third Military Medical University, Chongqing 400038 China
2Department of Laboratory Medical Science, Third Military Medical University, Chongqing 400038 China
Correspondence to Wei-Ke Si, Department of Clinical Biochemistry, Third Military Medical University, Chongqing 400038 China
Tel. 0086-23-68752314, 68752313
Email. lcshchem@mail.tmmu.com.cn
Received 2000-08-08 Accepted 2000-09-18
Study on matrine inhibiting proliferation of HepG2 cell and the relation between its dosage and inhibiting style
Wei-Ke Si1, Jing Pan2, Hua Lu2 and Zhao-Quan Li2
Abstract
AIM To study 0.05-3.5g·L-1 matrine inhibiting proliferation of human hepatoma cell HepG2 and the relation between its dosage and inhibiting style to lay a foundation for further study on its mechanism of action and for clinical application for tumor treatment. ......
您现在查看是摘要页,全文长 24677 字符。